Joint and rheumatic diseases cause significant, chronic health and societal burden, characterized by progressive impairment and long-term treatment needs. Effective management is multidisciplinary; pharmacists play a key role. This article examines pharmaceutical care’s impact on joint diseases, focusing on core care principles, therapy monitoring, and adherence strategies. Evidence shows pharmacists enhance patient outcomes by individualizing therapy, solving medication issues, educating patients, and ensuring follow-up. The need for structured pharmaceutical care in Bulgaria is highlighted, including clinical pharmacy development and national standards. Pharmacist-led care can improve outcomes and care quality for patients with joint diseases.
Epping-Jordan JE, Pruitt SD, Bengoa R, Wagner EH. Improving the quality of health care for chronic conditions. Qual Saf Health Care. 2004;13(4):299–305. doi:10.1136/qhc.13.4.299.
Dures E, Hewlett S. Cognitive–behavioural approaches to self-management in rheumatic disease. Nat Rev Rheumatol. 2012;8:553–559. doi:10.1038/nrrheum.2012.108.
Smolen JS. Treat-to-target: Rationale and strategies. Clin Exp Rheumatol. 2012;30:S2–S6.
Nikolov N, Panchovska-Mocheva M, Kolarov Zl. Current aspects of rheumatologic care in Bulgaria. Sofia: Bulgaria Publishing Group; 2013:112.
Rahayu SA, Widianto S, Defi IR, Abdulah R. Role of pharmacists in the interprofessional care team for patients with chronic diseases. J Multidiscip Healthc. 2021;14:1701–1710.
Hogan PF, Bouchery E. Workforce study of rheumatologists. The Lewin Group; 2006. Available at: http://www.rheumatology.org/Portals/0/Files/LewinReport.pdf (Accessed January 26, 2016).
Hustoft M, Biringer E, Gjesdal S, Aßus J, Hetlevik Ø. Relational coordination in interprofessional teams and its effect on patient-reported benefit and continuity of care: a prospective cohort study. BMC Health Serv Res. 2018;18:1–9. doi:10.1186/s12913-018-3536-5.
Iversen MD, Hammond A. Patient education in arthritis management. Best Pract Res Clin Rheumatol. 2010;24(1):119–32. doi:10.1016/j.berh.2009.09.011.
Barat E, Soubieux A, Brevet P, Gerard B, Vittecoq O, Lequerre T, et al. Impact of the clinical pharmacist in rheumatology practice: a systematic review. Healthcare. 2024;12(15):1463. doi:10.3390/healthcare12151463.
Simons G, Ismail N, Sandhu K, Mallen CD, Stack RJ, Pontefract S, Raza K, Falahee M. The potential role of community pharmacy staff in reducing patient delay in consulting with symptoms of rheumatoid arthritis: a qualitative study. BMC Rheumatol. 2022;6:50. doi:10.1186/s41927-022-00280-0.
Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, Laslett LL, Jones G, Cicuttini F, Osborne R, Vos T, Buchbinder R, Woolf A, March L. The global burden of hip and knee osteoarthritis. Ann Rheum Dis. 2014;73(7):1323–1330. doi:10.1136/annrheumdis-2013-204763.
Firestein GS, Budd RC, Gabriel SE, McInnes IB, O'Dell JR, editors. Firestein & Kelley’s textbook of rheumatology. 11th ed. Philadelphia: Elsevier; 2020.
Long H, Liu Q, Yin H, Wang K, Diao N, Zhang Y, Lin J, Guo A. Prevalence trends of site-specific osteoarthritis from 1990 to 2019. Arthritis Rheumatol. 2022;74(7):1172–1183. doi:10.1002/art.42089.
GBD 2021 Rheumatoid Arthritis Collaborators. Global, regional, and national burden of rheumatoid arthritis. Lancet Rheumatol. 2023;5(10):e594–e610. doi:10.1016/S2665-9913(23)00211-4.
National Council on Prices and Reimbursement of Medicinal Products. Pharmacotherapeutic guideline on rheumatology. Available at: https://www.ncpr.bg/images/farmako-terapevtichni/2019/01.04.2019/ftr_po_revmatologiia.pdf.
National Statistical Institute. Healthcare 2024 report. Available at: https://www.nsi.bg/file/17671/Zdraveopazvane_2024.pdf).
Chen S, Chen M, Wu X, Lin S, Tao C, Cao H, et al. Global burden of low back pain 1990–2019. J Orthop Translat. 2021;32:49–58. doi:10.1016/j.jot.2021.07.005.
Smolen JS, Landewé RBM, Bergstra SA, Kerschbaumer A, Sepriano A, Aletaha D, et al. EULAR recommendations for RA management: 2022 update. Ann Rheum Dis. 2023;82:3–18. doi:10.1136/ard-2022-223356.
Korovina MO, Valeeva AR, Akhtyamov IF, Brooks W, Renaudineau Y, Manukyan G, et al. Joint tissues: convergence and divergence of pathogenetic mechanisms of RA and OA. Int J Mol Sci. 2025;26(17):8742. doi:10.3390/ijms26178742.
Bruyère O, Cooper C, Pelletier JP, Branco J, Brandi ML, Guillemin F, et al. Algorithm recommendation for knee OA management. Semin Arthritis Rheum. 2014;44(3):253–63. doi:10.1016/j.semarthrit.2014.05.014.
Fraenkel L, Bathon JM, England BR, St Clair EW, Arayssi T, Carandang K, et al. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol. 2021;73(7):1108–1123. doi:10.1002/art.41752.
Tong L, Yu H, Huang X, Shen J, Xiao G, Chen L, et al. Current understanding of osteoarthritis pathogenesis and relevant new approaches. Bone Res. 2022;10(1):60. doi:10.1038/s41413-022-00226-9.
van der Heijde D, Ramiro S, Landewe R, Baraliakos X, Van den Bosch F, Sepriano A, et al. EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2017;76(6):978–991.
American College of Rheumatology. Guidelines for the Management of Osteoarthritis and Rheumatoid Arthritis. 2021.
Holroyd CR, Seth R, Bukhari M, Malaviya A, Holmes C, Curtis E, et al. The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis. Rheumatology. 2019;58(2):e3–e42. doi:10.1093/rheumatology/key208.
Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. ACR 2019 guidelines for osteoarthritis management. Arthritis Care Res. 2019;71(2):220–233.
Strand V, Khanna D. Patient-reported outcomes in rheumatology: relevance for pharmaceutical care. Rheumatology. 2019;58(Suppl 1):i12–i20.
Showande SJ, Akinbode TE. Nonsteroidal anti-inflammatory drug use by patients: impact of educational training on pharmacists’ counselling and risk assessment. Explor Res Clin Soc Pharm. 2024;15:100494. doi:10.1016/j.rcsop.2024.100494.
Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, et al. 2015 ACR Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol. 2016;68(1):1–26. doi:10.1002/art.39480.
Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2020;79:39–52.
Hayat K, Zaman H, Fang Y, Atif M. Management of rheumatoid arthritis and the pharmacist’s role. In: Encyclopedia of Pharmacy Practice and Clinical Pharmacy. 1st ed. Elsevier; 2019.
Carr K, Lucas K, Grantner GR. A review of rheumatoid arthritis for pharmacists. US Pharm. 2022;47(11):36–71.
O’Dell JR. Therapeutic strategies for rheumatoid arthritis. N Engl J Med. 2004;350(25):2591–2602. doi:10.1056/NEJMra040226.
Edwards CJ. The role of pharmacists in managing chronic inflammatory joint diseases. Int J Clin Pharm. 2020;42(4):875–83.
Koster ES, Blom L. Optimizing medication adherence in chronic musculoskeletal diseases. Int J Clin Pharm. 2022;44(2):345–56.
Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice: the patient-centered approach to medication management. 3rd ed. New York: McGraw-Hill; 2012.
Newman TV, San-Juan-Rodriguez A, Parekh N, Swart ECS, Klein-Fedyshin M, Shrank WH, et al. Impact of community pharmacist-led interventions in chronic disease management: an umbrella review. Res Social Adm Pharm. 2020;16(9):1155–1165. doi:10.1016/j.sapharm.2019.12.016.
World Health Organization. The role of the pharmacist in the health care system. Geneva: WHO; 1997.
Zerbini CAF, Machado PM, Hayashi F, Macedo PM, Azevedo VF, Kalil JR, et al. Pharmacovigilance and patient safety in rheumatology practice. Clin Rheumatol. 2018;37(6):1521–30.
Craske M, Hardeman W, Steel N, Twigg MJ. Pharmacist-led medication reviews: a scoping review of systematic reviews. PLoS ONE. 2024;19(9):e0309729. doi:10.1371/journal.pone.0309729.
Farhana L, Rahayu FP, Sholihah S, Sweileh W, Abdulah R, Alfian SD. Effectiveness of pharmacist-led intervention on medication adherence in chronic diseases: a systematic review. Patient Prefer Adherence. 2025;19:2161–2178. doi:10.2147/PPA.S530503.
Sholihah S, Rahayu FP, Farhana L, Alshehri S, Alfian SD, Abdulah R. Pharmacist-led interventions to improve medication adherence among patients with multimorbidity: a scoping review. Patient Prefer Adherence. 2025;19:3589–3602. doi:10.2147/PPA.S542881.
Drosos AA, Pelechas E, Kaltsonoudis E, Markatseli TE, Voulgari PV. Biologic therapies and autoimmune phenomena. Mediterr J Rheumatol. 2021;32(2):96–103. doi:10.31138/mjr.32.2.96.
Flick C, Farrell J. The pharmacist’s role in managing rheumatic diseases. The Rheumatologist. 2013;7(8).
Joplin S, van der Zwan R, Joshua F, Wong PK. Medication adherence in rheumatoid arthritis: effect of patient education, health literacy, and ultrasound. Biomed Res Int. 2015;2015:150658. doi:10.1155/2015/150658.
Iversen MD, Hammond A, Betteridge N. Self-management of rheumatic diseases: state of the art and future perspectives. Ann Rheum Dis. 2010;69(6):955–963. doi:10.1136/ard.2010.129270.
Li L, Cui Y, Yin R, Chen S, Zhao Q, Chen H, et al. Medication adherence has an impact on disease activity in rheumatoid arthritis: a systematic review and meta-analysis. Patient Prefer Adherence. 2017;11:1343–56.
Kim D, Choi JY, Cho SK, Choi CB, Bang SY, Cha HS, et al. Prevalence and associated factors for non-adherence in patients with rheumatoid arthritis. J Rheum Dis. 2018;25:47–57. doi:10.4078/jrd.2018.25.1.47.
World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003.
Ritschl V, Lackner A, Boström C, Mosor E, Lehner M, Omara M, et al. New insights on factors associated with non-adherence in rheumatoid arthritis. Arthritis Res Ther. 2018;20(1):234. doi:10.1186/s13075-018-1732-7.
Balsa A, García de Yébenes MJ, Carmona L, Garrido Courel L, Mendizábal J, Restrepo J, et al. Multilevel factors predict medication adherence in rheumatoid arthritis: a 6-month cohort study. Ann Rheum Dis. 2022;81(3):327–334. doi:10.1136/annrheumdis-2021-221163.
Mohamed M, El-Maboud A, Salem HF, Salem MN, Elmaaty MA, Eissa N, et al. Predictors of methotrexate adherence and patient’s awareness of it in rheumatoid arthritis and its effect on quality of life. J Pharm Policy Pract. 2024;17(1):2365933. doi:10.1080/20523211.2024.2365933.
Aksoy N, Ozturk N, Agh T, Kardas P. Adherence to antirheumatic drugs: a systematic review and meta-analysis. Front Med. 2024;11:1456251. doi:10.3389/fmed.2024.1456251.
Nieuwlaat R, Wilczynski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;2014(11):CD000011. doi:10.1002/14651858.CD000011.pub4.
Naqvi AA, Hassali MA, Naqvi SBS, Nadir MN, Khan YH, Mahmood S, et al. Impact of pharmacist educational intervention on disease knowledge, rehabilitation, medication adherence, treatment-induced direct cost, health-related quality of life and satisfaction in rheumatoid arthritis: study protocol for a randomized controlled trial. Trials. 2019;20:488. doi:10.1186/s13063-019-3540-z.
Haegens LL, Bekker CL, Flendrie M, van den Bemt BJF, Huiskes VJB. Text messaging between patients with inflammatory rheumatic diseases and pharmacists to solve drug-related problems: a prospective feasibility study. JMIR Hum Factors. 2025;12:e66514. doi:10.2196/66514.
Santschi V, Chiolero A, Burnand B, Colosimo AL, Paradis G. Impact of pharmacist care on the management of cardiovascular disease risk factors: a systematic review and meta-analysis. Arch Intern Med. 2011;171(16):1441–1453. doi:10.1001/archinternmed.2011.399.
Creagh AP, Hamy V, Yuan H, Rehman S, Sinclair J, Parkes M, et al. Digital health technologies and machine learning augment patient-reported outcomes to remotely characterise rheumatoid arthritis. npj Digit Med. 2024;7:33. doi:10.1038/s41746-024-01013-y.
Moon Z, Walsh J. Digital interventions in medication adherence: a narrative review. Front Pharmacol. 2025;16:1632474. doi:10.3389/fphar.2025.1632474.
Gajadhur K, Patil R, Anadachee AP, Kashyap A, Banerjee I. Effectiveness of digital health intervention in enhancing medication adherence among arthritis patients: a systematic review of RCTs. Nepal J Epidemiol. 2025;14(4):1362–1373. doi:10.3126/nje.v14i4.77347.
Kini V, Ho PM. Interventions to improve medication adherence: a review. JAMA. 2018;320(23):2461–2473. doi:10.1001/jama.2018.19271.
Peng Y, Wang H, Fang Q, Xie L, Shu L, Sun W, et al. Effectiveness of mobile applications on medication adherence in adults with chronic diseases: a systematic review and meta-analysis. J Manag Care Spec Pharm. 2020;26(4):550–561. doi:10.18553/jmcp.2020.26.4.550.
Salaffi F, Carotti M, Ciapetti A, Di Carlo M, Gasparini S, Farah S, et al. Effectiveness of a telemonitoring intensive strategy in early rheumatoid arthritis: comparison with conventional management. BMC Musculoskelet Disord. 2016;17:146. doi:10.1186/s12891-016-1002-2.
Santos-Moreno P, Rodríguez-Vargas GS, Casanova R, Rubio-Rubio JA, Chávez-Chávez J, Rivera-Triana DP, et al. Evaluation of a non-face-to-face multidisciplinary healthcare model in rheumatoid arthritis during the COVID-19 pandemic. Healthcare (Basel). 2021;9(12):1744. doi:10.3390/healthcare9121744.
Petkova VB. Education for arthritis patients: a community pharmacy-based pilot project. Pharm Pract (Granada). 2009;7(2):88–93. doi:10.4321/s1886-36552009000200004.
Stoimenova A, Draganov G, Manova M, Savova A, Petrova G. Role of pharmacists in the management of chronic diseases: hypertension. Cardiovascular Diseases. 2011;42(4):3–10.
Andreeva L, Todorova A. The role and position of pharmacists in the comprehensive care of patients with ankylosing spondylitis (Bechterew’s disease). Varna Med Forum. 2024;13(Suppl 2).
Petkova V, Georgiev S, Dimitrova ZL, Radivoeva M. Implementation of pharmaceutical care knowledge in Bulgarian community pharmacies. Pharmacy Education. 2018;6(2). Available at: https://pharmacyeducation.fip.org/pharmacyeducation/article/view/99
Stoynova R, Gvozdeva Y, Peikova L, Mihaylova A. Bulgarian community pharmacists’ attitudes and barriers towards pharmaceutical care provision for pregnant women. Pharmacia. 2021;68(3):511–6. doi:10.3897/pharmacia.68.e68651.
Email this article (Login required) 
